Creative Medical Technology (CELZ) Competitors $2.97 -0.12 (-3.82%) As of 11:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. ITRM, ESLA, KZR, OKUR, CING, FGEN, TPST, SCYX, MIRA, and JATTShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Iterum Therapeutics (ITRM), Estrella Immunopharma (ESLA), Kezar Life Sciences (KZR), OnKure Therapeutics (OKUR), Cingulate (CING), FibroGen (FGEN), Tempest Therapeutics (TPST), SCYNEXIS (SCYX), MIRA Pharmaceuticals (MIRA), and JATT Acquisition (JATT). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Iterum Therapeutics Estrella Immunopharma Kezar Life Sciences OnKure Therapeutics Cingulate FibroGen Tempest Therapeutics SCYNEXIS MIRA Pharmaceuticals JATT Acquisition Iterum Therapeutics (NASDAQ:ITRM) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations. Which has more volatility and risk, ITRM or CELZ? Iterum Therapeutics has a beta of 2.85, meaning that its stock price is 185% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. Does the media refer more to ITRM or CELZ? In the previous week, Iterum Therapeutics had 2 more articles in the media than Creative Medical Technology. MarketBeat recorded 6 mentions for Iterum Therapeutics and 4 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 1.06 beat Iterum Therapeutics' score of -0.12 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iterum Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Creative Medical Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, ITRM or CELZ? Creative Medical Technology has higher revenue and earnings than Iterum Therapeutics. Iterum Therapeutics is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIterum TherapeuticsN/AN/A-$24.77M-$0.85-1.00Creative Medical Technology$6K1,280.93-$5.49M-$3.18-0.93 Is ITRM or CELZ more profitable? Iterum Therapeutics' return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Iterum TherapeuticsN/A N/A -65.01% Creative Medical Technology N/A -82.99%-79.49% Do analysts prefer ITRM or CELZ? Iterum Therapeutics presently has a consensus price target of $9.00, indicating a potential upside of 963.83%. Given Iterum Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Iterum Therapeutics is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iterum Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in ITRM or CELZ? 9.2% of Iterum Therapeutics shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 2.4% of Iterum Therapeutics shares are held by company insiders. Comparatively, 1.8% of Creative Medical Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryIterum Therapeutics beats Creative Medical Technology on 10 of the 14 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.66M$3.07B$5.59B$9.83BDividend YieldN/A2.29%4.64%4.14%P/E Ratio-0.9320.4830.0325.46Price / Sales1,280.93360.69456.96105.13Price / CashN/A40.7837.7258.50Price / Book1.127.708.436.04Net Income-$5.49M-$54.75M$3.26B$265.10M7 Day Performance-15.33%3.29%2.85%2.20%1 Month Performance2.13%11.07%5.36%3.32%1 Year Performance-16.98%13.07%42.25%25.51% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.5799 of 5 stars$2.97-3.8%N/A-9.4%$7.66M$6K-0.935Positive NewsEarnings ReportGap UpHigh Trading VolumeITRMIterum Therapeutics2.2341 of 5 stars$0.70-2.6%$9.00+1,194.2%-31.6%$30.07MN/A-0.7010News CoverageGap UpESLAEstrella Immunopharma3.1378 of 5 stars$0.85+2.0%$16.00+1,793.5%-38.2%$29.96MN/A-3.25N/AAnalyst ForecastGap UpKZRKezar Life Sciences3.8236 of 5 stars$4.07-0.7%$39.50+870.5%-34.0%$29.95M$7M-0.3860OKUROnKure Therapeutics3.4722 of 5 stars$2.16-0.5%$32.33+1,396.9%N/A$29.25MN/A-0.41N/ANews CoverageEarnings ReportGap UpCINGCingulate3.2101 of 5 stars$5.42-3.4%$26.00+379.7%+43.5%$28.87MN/A-0.6420News CoverageFGENFibroGen4.5957 of 5 stars$6.91-0.3%$250.00+3,517.9%-3.9%$28.01M$29.62M-2.76570News CoverageEarnings ReportTPSTTempest Therapeutics3.0584 of 5 stars$7.39-0.9%$30.00+306.0%-29.2%$27.47MN/A-0.4120News CoveragePositive NewsEarnings ReportUpcoming EarningsSCYXSCYNEXIS1.1832 of 5 stars$0.71+1.9%N/A-51.1%$27.16M$3.75M-1.2760News CoverageUpcoming EarningsMIRAMIRA Pharmaceuticals2.3202 of 5 stars$1.53-2.5%$17.00+1,011.1%-30.3%$26.56MN/A-3.002News CoverageGap DownJATTJATT AcquisitionN/A$1.50+7.1%N/A-58.4%$25.88MN/A0.003Gap UpHigh Trading Volume Related Companies and Tools Related Companies Iterum Therapeutics Alternatives Estrella Immunopharma Alternatives Kezar Life Sciences Alternatives OnKure Therapeutics Alternatives Cingulate Alternatives FibroGen Alternatives Tempest Therapeutics Alternatives SCYNEXIS Alternatives MIRA Pharmaceuticals Alternatives JATT Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access